心血管代谢综合征中的生活方式干预 JACC:专家小组取得了进展
Izza Shahid1, Jerrin Philip2, Eleonora Avenatti2
1Division of Preventive Cardiology, Houston Methodist Academic Institute, Houston, Texas, USA.
JACC. Advances
|June 27, 2025
概括
生活方式干预对于管理心血管--代谢 (CKM) 综合征在各个阶段至关重要. 这些可访问的策略有助于预防疾病的进展,并减少不良结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢疾病 代谢疾病
- 预防医学 预防医学
背景情况:
- 心血管 - - 代谢 (CKM) 综合征对全球健康造成重大负担.
- 渐进性CKM综合征功能障碍导致广泛的发病率和死亡率.
- 对于CKM综合征的管理,需要可访问的,低成本的干预措施.
研究的目的:
- 审查关于CKM综合征生活方式干预的随机临床试验的证据.
- 探索生活方式干预措施在CKM综合征不同阶段的影响.
- 检查生活方式的改变如何影响CKM综合征中相互关联的系统.
主要方法:
- 随机临床试验的系统审查.
- 分析生活方式干预措施 (饮食,体育活动,行为改变).
- 根据CKM综合征阶段 (0-4) 的干预措施分层.
主要成果:
- 生活方式干预是CKM综合征管理的基础.
- 证据支持生活方式干预在初级预防 (阶段0-2).
- 生活方式干预在亚临床 (阶段3) 和流行 (阶段4) CKM 疾病中显示出好处.
结论:
- 对于CKM综合征的所有阶段,非药物生活方式干预是必不可少的.
- 有针对性的生活方式改变可以预防疾病的进展,并减轻不良后果.
- 了解系统相互作用是优化CKM综合征生活方式干预措施的关键.
相关概念视频
Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
Hypertension III: Clinical Manifestations and Diagnostic Studies
58
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
58
Hypertension IV: Drug Therapy and Lifestyle Modifications
51
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
51
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82


